Get started
Author

Stavroula Masouridi‐Levrat

Observed names: Masouridi-Levrat, Stavroula, S Masouridi-Levrat, S. Masouridi-Levrat, S. Masouridi‐Levrat, Stavroula Masouridi-Levrat, Stravoula Masouridi-Levrat
ORCID: 0000-0001-7502-5454
Observed ORCID: 0000-0001-7502-5454
OpenAlex ID: A5003196039
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study
2018 · Olga Chatzis, Stephanie Darbre, et al. · BMC Infectious Diseases · 119
PDF
Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
2016 · Stavroula Masouridi-Levrat, Federico Simonetta, et al. · Frontiers in Immunology · 80
PDF
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
2019 · Federico Simonetta, Amandine Pradier, et al. · Frontiers in Immunology · 46
PDF
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation
2020 · Amandine Pradier, Stavroula Masouridi-Levrat, et al. · Frontiers in Immunology · 45
PDF
Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies
2015 · S Masouridi-Levrat, A Pradier, et al. · Bone Marrow Transplantation · 44
Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease
2021 · M. C. Zanella, S. Cordey, et al. · Microbiome · 43
PDF
Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation
2018 · D.-L. Vu, S. Cordey, et al. · Clinical Microbiology and Infection · 42
PDF
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation
2017 · Federico Simonetta, Amandine Pradier, et al. · Transplantation · 42
PDF
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
2021 · Anne-Claire Mamez, Amandine Pradier, et al. · Bone Marrow Transplantation · 38
PDF
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation
2019 · Stéphane Buhler, Florence Bettens, et al. · Leukemia · 36
PDF
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
2021 · Léna Royston, Eva Royston, et al. · Vaccines · 32
PDF
Prise en charge pratique du syndrome de relargage des cytokines (CRS) post-CAR-T cells chez l’adulte et l’enfant : recommandation de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
2019 · Ibrahim Yakoub-Agha, Anne-Sophie Moreau, et al. · Bulletin du Cancer · 31
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin
2015 · Federico Simonetta, Amandine Pradier, et al. · The Journal of Immunology · 29
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
2023 · Lara Chavaz, Léna Royston, et al. · Open Forum Infectious Diseases · 27
PDF
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
2021 · Romain Samuel Roth, Stavroula Masouridi-Levrat, et al. · Open Forum Infectious Diseases · 26
PDF
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
2021 · Léna Royston, Eva Royston, et al. · Immunity Inflammation and Disease · 26
PDF
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients
2020 · Mateja Kraljevic, Nina Khanna, et al. · Medical Mycology · 23
PDF
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients
2023 · Davide Bosetti, Chiara Bernardi, et al. · Antimicrobial Agents and Chemotherapy · 22
PDF
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study
2020 · Diem‐Lan Vu, Julie‐Anne Dayer, et al. · Transplant Infectious Disease · 21
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
2022 · Léna Royston, Stavroula Masouridi-Levrat, et al. · Antimicrobial Agents and Chemotherapy · 18
Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis
2019 · Jocelyne Piret, Manuel Schibler, et al. · The Journal of Infectious Diseases · 18
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation
2021 · Stéphane Buhler, Helen Baldomero, et al. · Blood Advances · 17
PDF
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation
2024 · Antonia Schäfer, Zuleika Calderin Sollet, et al. · Blood Advances · 16
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption
2023 · Sarah Morin, Federica Giannotti, et al. · Frontiers in Oncology · 16
PDF
Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience
2021 · Ilona Kronig, Stavroula Masouridi-Levrat, et al. · Mycopathologia · 16
PDF
Works count: 113
Citation count: 1,184
H-index: 19
I10-index: 36
Year
Topic
Type